Copyright
©The Author(s) 2004.
World J Gastroenterol. Aug 15, 2004; 10(16): 2406-2408
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2406
Published online Aug 15, 2004. doi: 10.3748/wjg.v10.i16.2406
Effusion group | n | Positivity (%) | Expression intensity | |||
– | + | ++ | +++ | |||
Malignant | 35 | 30 (85.7) | 5 | 2 | 21 | 7 |
Benign | 37 | 3 (8.1) | 34 | 1 | 2 | 0 |
Effusion group | n | Positivity (%) | Expression intensity | |||
– | + | ++ | +++ | |||
Malignant | 35 | 4 (11.4) | 31 | 1 | 3 | 0 |
Benign | 37 | 35 (94.6) | 2 | 0 | 0 | 35 |
Index | Malignant effusion (%) | Benign effusion (%) | ||
E-cadherin | E(+) + C(-) | Calretinin | E(-) + C(+) | |
Sensitivity | 85.7 | 77.1 | 94.6 | 86.5 |
Specificity | 91.9 | 100 | 88.6 | 97.1 |
PV+ | 90.9 | 100 | 89.7 | 97.0 |
PV- | 87.2 | 82.2 | 93.9 | 87.2 |
DAR | 88.9 | 88.9 | 91.7 | 91.7 |
- Citation: He DN, Zhu HS, Zhang KH, Jin WJ, Zhu WM, Li N, Li JS. E-cadherin and calretinin as immunocytochemical markers to differentiate malignant from benign serous effusions. World J Gastroenterol 2004; 10(16): 2406-2408
- URL: https://www.wjgnet.com/1007-9327/full/v10/i16/2406.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i16.2406